Latest receivables for SXTPW: $340K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
60 Degrees Pharmaceuticals- Warrants (16/05/2028) posts a receivables of $340K as of March 2026. That compares with $490K in the prior-year period — down 31.2% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, 60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s receivables was $490K. The latest reading is $340K — a 31.2% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.
Receivables is one piece of 60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s financial statement story. At $340K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for SXTPW's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; 60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s other metric pages and overview cover the third.